Category Archives: Medical

CL diagnostic tool cleared by FDA

290px-USAMRIID_Logo

The U.S. Food and Drug Administration approved a device that will provide rapid diagnosis of cutaneous leishmaniasis (CL), the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) announced on Nov. 14. USAMRIID partnered with InBios International, Inc., the Institut … Read More »

HHS seeks information on formulating new Ebola vaccines

140px-US-DeptOfHHS-Seal.svg

The U.S. Department of Health and Human Services is looking for vendor information to fill new drug products as it continues its efforts to combat the recent Ebola epidemic in West Africa. Issued on Friday, the Request for Information seeks … Read More »

Cempra receives $16 million from BARDA for drug study

Cempra

Cempra, Inc., announced on Thursday that is will receive an additional $16 million from the Biomedical Advanced Research and Development Authority (BARDA) for two clinical studies of its drug solithromycin on pediatric patients with bacterial infections. The antibiotic will be … Read More »

PharmAthene fulfills BARDA anthrax countermeasure contract

pharmathene

Pharmaceutical developer PharmAthene said on Thursday that it has fulfilled a contract from the Biomedical Advanced Research and Development Authority (BARDA) to develop an anti-anthrax compound. The contract, finalized in November 2013, stipulated the company be able to provide an … Read More »

EU releases Ebola relief effort summary

125px-Flag_of_Europe.svg

The European Union (EU) released on Tuesday its response to the ongoing situation in West Africa, where the Ebola virus has infected more than 13,000 people and caused approximately 5,000 deaths since the outbreak began in December 2013. The EU … Read More »

Steuben County Public Health utilizes phone system to monitor Ebola risk

Steuben County Public Health

At the Steuben County Public Health Department appointments are set up entirely by phone. The department opted to use this existing infrastructure to its advantage as a way to pinpoint the risk of Ebola transmission within local clinics. “We are … Read More »

House subcommittee to hold hearing on Ebola medical developments

170px-Seal_of_the_United_States_House_of_Representatives.svg

A subcommittee of the House Energy and Commerce Committee will hold a meeting on Nov. 19 to discuss medical developments in response to the Ebola outbreak. The hearing will start at 10 a.m. in the 2123 Rayburn House Office Building. … Read More »

G-20 leaders call for more support to Ebola-affected countries

G20 brisbane australia

G20 leaders in Brisbane, Australia, recently made a statement calling for more support to the governments of countries most affected by the Ebola virus. Guinea, Liberia and Sierra Leone are “making tremendous efforts” to combat the outbreak of the virus, … Read More »

NanoViricides to continue work on Ebola, Dengue fever vaccines

NanoViricides, Inc., is moving forward with its development of Ebola and Dengue Fever vaccines, as well as  other drug candidates, the company announced on Monday. The company recently signed an agreement with the U.S. Army Medical Research Institute of Infectious … Read More »

Hungary latest EU nation to sign Joint Procurement Agreement

125px-Flag_of_Europe.svg

Hungary this week became the 18th European Union (EU) country to sign the Joint Procurement Agreement to procure medical countermeasures. The 2009 outbreak of H1N1 pandemic influenza, also known as avian flu, showcased a weakness in the development, production and … Read More »

Integral Molecular to study immune response to Ebola, Hepatitis C for NIH

Integral Molecular

The National Institutes of Health (NIH) awarded on Thursday a $3.5 million contract to Integral Molecular to study the human immune responses to Ebola and hepatitis C (HCV). The research will focus on the response of antibodies upon infection and … Read More »

Countervail to develop anti-nerve agent compound

Countervail

Countervail Corp. announced on Saturday that it has received an additional $5.4 million from the Department of Homeland Security and the Biomedical Advanced Research and Development Authority (BARDA) to research nerve agent counter measures. The company is to continue the … Read More »

AFB testimony urges better preventative measures

alliance for biosecurity

The Alliance for BioSecurity (AFB), a consortium of companies that develop biological defense products, recently submitted a written testimony calling for research support to develop vaccines and treatment options for deadly diseases. The outbreak of Ebola in West Africa brings … Read More »

U.S. hospitals to be supplied Ebola protective equipment

Microscopic view of the Ebola virus

The U.S. Centers for Disease Control and Prevention (CDC) said on Friday that $2.7 million worth of personal protection equipment will be sent to hospitals to assist in the care of Ebola patients. Altogether, 50 kits have been prepared and … Read More »

Results of Aethlon’s Hemopurifier therapy on Ebola patient to be released

aethlon_ex99010

Results from a new treatment that may help fight Ebola will be released on Nov. 14 in Philadelphia. Hemopurifier therapy from Aethlon Medical was given to a patient infected with the virus at Frankfurt University Hospital in Germany. On Nov. … Read More »